A Preview Of CymaBay Therapeutics's Earnings


CymaBay Therapeutics CBAY is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement.

Analysts estimate that CymaBay Therapeutics will report an earnings per share (EPS) of $-0.26.

CymaBay Therapeutics bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed EPS by $0.07, which was followed by a 0.93% increase in the share price the next day.

Here's a look at CymaBay Therapeutics's past performance and the resulting price change:

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.26 -0.27 -0.24 -0.20
EPS Actual -0.33 -0.34 -0.25 -0.23
Price Change % 0.93% -8.33% 4.5% -2.18%

Stock Performance

Shares of CymaBay Therapeutics were trading at $2.97 as of March 15. Over the last 52-week period, shares are down 36.79%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

If you want to track all upcoming earnings announcements, check out our Earnings Calendar here

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Posted In: EarningsBZI-EP
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!